Civica’s $27.8m New Facility Expands Virginia Drug Hub Vision

Meanwhile, CivicaScript Targets Prostate Cancer With First Product Launch

Civica has announced a further $27.8m investment to support its plans for insulin and other essential medicines. The news comes shortly after CivicaScript announced its first launch in the form of abiraterone tablets.

Silhouette of construction workers against metal structure and the sky
Civica is building out its capabilities in Virginia • Source: Shutterstock

Civica Inc. has announced plans to invest $27.8m into a new 55,000 square-foot laboratory testing facility in Meadowville Technology Park, Chesterfield County in Virginia, US.

More from Manufacturing

More from Business